Witryna21 lis 2014 · Nissen believes IMPROVE-IT is a positive trial, and despite flaws, it is a statistically valid result. He pointed out that the treatment effect was observed in a very high-risk patient population ... Witrynaczasownik. poprawiać się, poprawiać, ulepszać, polepszać, usprawniać, usprawnić [przechodni/nieprzechodni] to make something better. My English has improved since …

Benefit of Adding Ezetimibe to Statin Therapy on ... - Circulation

Witryna31 maj 2024 · In summary, the DANAMI-3 PRIMULTI trial provides further evidence that treatment of non-infarct related arteries discovered during STEMI is beneficial, and suggests that the use of FFR-guidance remains beneficial even in the recent ACS setting. The subsequent Compare-Acute trial showed similar findings. On the strength of … WitrynaThe IMPROVE-IT trial is a landmark clinical trial that demonstrated the incremental clinical benefit of adding a non-statin (ezetimibe) to a statin (simvasta... songs wust.edu.cn

www.almaany.com

http://cardiologytrials.org/detail/107/ WitrynaHans Klingemann and Sally Arai completed a US trial at Rush University Medical Center ( Chicago) in renal cell cancer and melanoma patients in 2008, [4] and Torsten Tonn, MD and Oliver Ottmann, MD completed the European trial at the University of Frankfurt in patients with various solid and hematological malignancies in 2013. [5] WitrynaExpert opinion: The results from IMPROVE-IT revalidated the concept that low-density lipoprotein cholesterol (LDL-C) levels are a clinically relevant treatment goal. This trial also suggested that further decrease of LDL-C levels (53 vs. 70 mg/dl; 1.4 vs. 1.8 mmol/l) was more beneficial in lowering CV events. songsxh 126.com